These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11692154)

  • 41. Gly40Ser mutation of glucagon receptor gene and essential hypertension in Japanese.
    Fujisawa T; Ikegami H; Babaya N; Ogihara T
    Hypertension; 1996 Dec; 28(6):1100. PubMed ID: 8952603
    [No Abstract]   [Full Text] [Related]  

  • 42. Role of the Gly40Ser mutation in the glucagon receptor gene in Brazilian patients with type 2 diabetes mellitus.
    Shiota D; Kasamatsu T; Dib SA; Chacra AR; Moisés RS
    Pancreas; 2002 May; 24(4):386-90. PubMed ID: 11961492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of Gly40Ser polymorphism of the glucagon receptor (GCGR) gene in different ethnic groups.
    Barbato A; Russo P; Venezia A; Strazzullo V; Siani A; Cappuccio FP
    J Hum Hypertens; 2003 Aug; 17(8):577-9. PubMed ID: 12874616
    [No Abstract]   [Full Text] [Related]  

  • 44. Hypothesis: glucagon receptor glycine to serine missense mutation contributes to one in 20 cases of essential hypertension.
    Morris BJ; Chambers SM
    Clin Exp Pharmacol Physiol; 1996 Dec; 23(12):1035-7. PubMed ID: 8977155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gly40Ser substitution in the glucagon receptor is rarely involved in the pathogenesis of NIDDM in Japanese patients.
    Odawara M; Matsunuma A; Yamashita K
    Diabetes Care; 1996 May; 19(5):547. PubMed ID: 8732726
    [No Abstract]   [Full Text] [Related]  

  • 46. Determinants of the renal clearance of exogenous lithium in a large sample of a white male working population.
    Cappuccio FP; Strazzullo P
    Clin Sci (Lond); 1993 Oct; 85(4):479-85. PubMed ID: 8222515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Segmental renal sodium handling in relation to the human SAH gene.
    Jin Y; Kuznetsova T; Tikhonoff V; Maillard M; Bochud M; Burnier M; Hasenkamp S; Brand E; Brand-Herrmann SM; Richart T; Staessen JA
    Hypertension; 2008 Aug; 52(2):e12-3. PubMed ID: 18519841
    [No Abstract]   [Full Text] [Related]  

  • 48. Na+, kidney, hypertension and genes: lessons from rats.
    Bianchi G; Tripodi G; Manunta P
    J Hypertens; 2004 Aug; 22(8):1461-4. PubMed ID: 15257164
    [No Abstract]   [Full Text] [Related]  

  • 49. The natriuretic hormone and hypertension.
    de Wardener HE; MacGregor GA
    J Chronic Dis; 1981; 34(6):233-8. PubMed ID: 7016890
    [No Abstract]   [Full Text] [Related]  

  • 50. AGEs and renal sodium handling: association with hypertension.
    Suzuki D; Hoshide S; Kario K
    Hypertens Res; 2022 Apr; 45(4):741-743. PubMed ID: 35046513
    [No Abstract]   [Full Text] [Related]  

  • 51. Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study.
    Winther-Sørensen M; Garcia SL; Bartholdy A; Ottenheijm ME; Banasik K; Brunak S; Sørensen CM; Gluud LL; Knop FK; Holst JJ; Rosenkilde MM; Jensen MK; Wewer Albrechtsen NJ
    Diabetologia; 2024 Aug; 67(8):1602-1615. PubMed ID: 38705923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downregulation of the kidney glucagon receptor, essential for renal function and systemic homeostasis, contributes to chronic kidney disease.
    Wang MY; Zhang Z; Zhao S; Onodera T; Sun XN; Zhu Q; Li C; Li N; Chen S; Paredes M; Gautron L; Charron MJ; Marciano DK; Gordillo R; Drucker DJ; Scherer PE
    Cell Metab; 2024 Mar; 36(3):575-597.e7. PubMed ID: 38237602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal potassium handling in carriers of the Gly40Ser mutation of the glucagon receptor suggests a role for glucagon in potassium homeostasis.
    Bankir L; Barbato A; Russo O; Crambert G; Iacone R; Bouby N; Perna L; Strazzullo P
    Physiol Rep; 2018 Apr; 6(8):e13661. PubMed ID: 29671960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered renal sodium handling and risk of incident hypertension: Results of the Olivetti Heart Study.
    D'Elia L; Cappuccio FP; Iacone R; Russo O; Galletti F; Strazzullo P
    PLoS One; 2017; 12(2):e0171973. PubMed ID: 28196131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Action and therapeutic potential of oxyntomodulin.
    Pocai A
    Mol Metab; 2014 Jun; 3(3):241-51. PubMed ID: 24749050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory mechanism of an allosteric antibody targeting the glucagon receptor.
    Mukund S; Shang Y; Clarke HJ; Madjidi A; Corn JE; Kates L; Kolumam G; Chiang V; Luis E; Murray J; Zhang Y; Hötzel I; Koth CM; Allan BB
    J Biol Chem; 2013 Dec; 288(50):36168-78. PubMed ID: 24189067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unraveling oxyntomodulin, GLP1's enigmatic brother.
    Pocai A
    J Endocrinol; 2012 Dec; 215(3):335-46. PubMed ID: 23019069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetics of salt-sensitive hypertension.
    Strazzullo P; Galletti F
    Curr Hypertens Rep; 2007 Mar; 9(1):25-32. PubMed ID: 17362668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proximal tubular function and salt sensitivity.
    Burnier M; Bochud M; Maillard M
    Curr Hypertens Rep; 2006 Apr; 8(1):8-15. PubMed ID: 16600154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic syndrome and renal sodium handling in three ethnic groups living in England.
    Barbato A; Cappuccio FP; Folkerd EJ; Strazzullo P; Sampson B; Cook DG; Alberti KG
    Diabetologia; 2004 Jan; 47(1):40-6. PubMed ID: 14618235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.